Medical Net, Inc.
3645.T · JPX
5/31/2025 | 5/31/2024 | 5/31/2023 | 5/31/2022 | |
|---|---|---|---|---|
| Revenue | ¥6,071 | ¥5,252 | ¥4,501 | ¥3,746 |
| % Growth | 15.6% | 16.7% | 20.2% | – |
| Cost of Goods Sold | ¥4,112 | ¥3,411 | ¥2,720 | ¥2,286 |
| Gross Profit | ¥1,960 | ¥1,841 | ¥1,781 | ¥1,460 |
| % Margin | 32.3% | 35.1% | 39.6% | 39% |
| R&D Expenses | ¥0 | ¥7 | ¥0 | ¥8 |
| G&A Expenses | ¥0 | ¥173 | ¥157 | ¥149 |
| SG&A Expenses | ¥1,865 | ¥1,542 | ¥1,401 | ¥1,010 |
| Sales & Mktg Exp. | ¥0 | ¥119 | ¥119 | ¥108 |
| Other Operating Expenses | ¥0 | -¥6 | ¥0 | -¥3 |
| Operating Expenses | ¥1,865 | ¥1,543 | ¥1,401 | ¥1,015 |
| Operating Income | ¥94 | ¥298 | ¥380 | ¥445 |
| % Margin | 1.6% | 5.7% | 8.4% | 11.9% |
| Other Income/Exp. Net | -¥69 | -¥145 | -¥129 | ¥89 |
| Pre-Tax Income | ¥25 | ¥153 | ¥251 | ¥534 |
| Tax Expense | ¥63 | ¥127 | ¥142 | ¥138 |
| Net Income | -¥68 | ¥6 | ¥116 | ¥380 |
| % Margin | -1.1% | 0.1% | 2.6% | 10.1% |
| EPS | -7.64 | 0.66 | 12.97 | 43.44 |
| % Growth | -1,257.6% | -94.9% | -70.1% | – |
| EPS Diluted | -7.64 | 0.66 | 12.97 | 43.44 |
| Weighted Avg Shares Out | 9 | 9 | 9 | 9 |
| Weighted Avg Shares Out Dil | 9 | 9 | 9 | 9 |
| Supplemental Information | – | – | – | – |
| Interest Income | ¥4 | ¥1 | ¥1 | ¥1 |
| Interest Expense | ¥12 | ¥6 | ¥3 | ¥2 |
| Depreciation & Amortization | ¥77 | ¥54 | ¥62 | ¥35 |
| EBITDA | ¥113 | ¥213 | ¥316 | ¥571 |
| % Margin | 1.9% | 4.1% | 7% | 15.2% |